Bendit (Bendamustine) 100 mg

Indicated for the treatment of specific blood cancers:

• 🩸 Chronic Lymphocytic Leukemia (CLL): First-line treatment for patients not eligible for fludarabine combination therapy.
• 🎗️ Indolent Non-Hodgkin Lymphoma (NHL): For patients who have progressed during or following treatment with rituximab regimens.
• ☠️ Multiple Myeloma: Stage II/III (in combination with prednisone).

Packaging: Single Dose Vial (100 mg lyophilized powder).

⚠️ ADMINISTRATION PROTOCOL (IV Only):

• 🧪 Reconstitution: Dissolve powder in Sterile Water for Injection, then dilute in 0.9% Sodium Chloride (NaCl).
• 💉 Infusion: Administer as an intravenous infusion over 30–60 minutes. DO NOT push as a bolus.
• 📅 Regimen: Typically given on Days 1 and 2 of a 21 or 28-day cycle.
• 🛑 Extravasation: Ensure the needle is in the vein; leakage causes severe tissue damage.

• Severe hepatic impairment (liver damage).
• Severe myelosuppression (neutrophil count < 1,500/µL or platelets < 75,000/µL).
• Pregnancy and breastfeeding.
• Recent major surgery.
• Live virus vaccines (e.g., Yellow Fever vaccine).